Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. During the call, all participants will be in a listen-only mode.
Lifecore Biomedical Inc. (LFCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Greenhaven Road Investment Management Scott Stewart Miller | 3,616,146 | $25,457,668 | 10.38% | |
| 2. | Hurley Capital Charles Goldblum | 5,000 | $35,200 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.74 | 17,000 | Officer, Director | 559,717 | 2025-01-08 | Filing | |
| $4.10 | 169,753 | Large Shareholder | 2,607,433 | 2024-10-03 | Filing | |
| $4.10 | 122,930 | Large Shareholder | 2,095,783 | 2024-10-03 | Filing | |
| $4.10 | 152,102 | Large Shareholder, Director | 319,286 | 2024-10-03 | Filing | |
| $4.10 | 1,311,312 | Large Shareholder, Director | 4,084,268 | 2024-10-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.01 | 15,847 | 1,714,070 | 2025-05-07 | Filing | ||
| $7.05 | 701 | 1,729,917 | 2025-05-06 | Filing | ||
| $7.08 | 24,543 | 1,730,618 | 2025-05-05 | Filing | ||
| $13.36 | 9,239 | Officer | 58,929 | 2018-05-09 | Filing | |
| $13.85 | 163 | Officer | 68,168 | 2018-04-25 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,764,919 | $12,425,030 | 0% | |
| 2. | 145,900 | $1,027,136 | 0% | |
| 3. | 83,663 | $588,987 | 0% | |
| 4. | 46,062 | $324,276 | 0.01% | |
| 5. | 24,730 | $174,092 | 0% |
News See All
Greenhaven Road Capital’s Updates on Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Micro Cap Stocks to Buy Now
Just as we overlook loose change, micro-cap stocks are often ignored for larger, more dominant enterprises.
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for joining LifeCor's financial 2025 second quarter earnings call. During the call, all participants will be in a listen-only mode.
Here’s Why Arquitos Capital Management Largely Exited Lifecore (LFCR)
Arquitos Capital Management, an investment management firm, released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR)
Greenhaven Road Capital, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lifecore's Fiscal 2025 First Quarter Earnings Call. During the presentation, all participants will be in a listen-only mode.
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Lifecore Biomedical Q4 and Full Year 2024 Earnings Call. At this time all participants are in a listen-only mode.
Laughing Water Capital is Waiting for an Investor Update from Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
